Patrick W. Smith - 29 Jan 2025 Form 4 Insider Report for Oncocyte Corp (OCX)

Reporting relationship: 10%+ Owner
Issuer ticker: OCX
Reported as of: 29 Jan 2025
Net transaction value: +$8,438
SEC form: 4
Accepted by SEC: 31 Jan 2025, 17:00:11 UTC
Prior SEC filing: 15 Jan 2025
Next SEC filing: 04 Feb 2025
Source filing: View source filing
Reporting owner signature: /s/ Patrick W. Smith

Key filing fact

Patrick W. Smith filed Form 4 for Oncocyte Corp (OCX) on 31 Jan 2025.

Key facts

This page summarizes Patrick W. Smith's Form 4 filing for Oncocyte Corp (OCX).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 31 Jan 2025, 17:00.

Change

Previous filing in this sequence was filed on 15 Jan 2025.
Current net transaction value: +$8,438.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OCX transaction

Common Stock, no par value

Purchase

Transaction value: $7,799
Shares: +3,880
Change %: +0.22%
Price: $2.01
Shares after: 1,793,838
Date: 29 Jan 2025
Ownership: See footnote
Footnotes: F1

OCX transaction

Common Stock, no par value

Purchase

Transaction value: $639
Shares: +318
Change %: +0.02%
Price: $2.01
Shares after: 1,794,156
Date: 30 Jan 2025
Ownership: See footnote
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares of common stock reported herein are directly held by PATRICK W SMITH TTEE THE SMITH IRREVOCABLE TRUST U/A DTD 05/01/2015 (the "Trust"). As the trustee of the Trust, the Reporting Person may be deemed to beneficially own the securities held by the Trust.